Biodesix Files Definitive Proxy Statement

Ticker: BDSX · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1439725

Biodesix Inc DEF 14A Filing Summary
FieldDetail
CompanyBiodesix Inc (BDSX)
Form TypeDEF 14A
Filed DateApr 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

TL;DR

Biodesix DEF 14A filed. Annual meeting proxy stuff. Vote your shares.

AI Summary

Biodesix Inc. filed its definitive proxy statement (DEF 14A) on April 28, 2025, for the fiscal year ending December 31, 2024. The company, headquartered in Louisville, Colorado, is seeking shareholder approval for matters related to its annual meeting. This filing is a routine disclosure required for publicly traded companies.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance and upcoming decisions, allowing them to make informed voting choices.

Risk Assessment

Risk Level: low — This is a standard DEF 14A filing, which is a routine disclosure for public companies and does not inherently present new risks.

Key Numbers

  • 2024-12-31 — Fiscal Year End (The period covered by the proxy statement.)
  • 20250428 — Filing Date (The date the definitive proxy statement was filed with the SEC.)

Key Players & Entities

  • BIODESIX INC (company) — Registrant
  • 0001439725 (company) — Central Index Key
  • 919 WEST DILLON ROAD (company) — Business Address
  • LOUISVILLE (company) — City
  • CO (company) — State
  • 80027 (company) — ZIP Code

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is a document filed with the SEC by a company that is soliciting its shareholders' votes on important matters, such as the election of directors or executive compensation.

When is Biodesix Inc.'s fiscal year end?

Biodesix Inc.'s fiscal year ends on December 31.

When was this definitive proxy statement filed?

This definitive proxy statement was filed on April 28, 2025.

Where is Biodesix Inc. headquartered?

Biodesix Inc. is headquartered in Louisville, Colorado.

Is this a preliminary or definitive proxy statement?

This is a definitive proxy statement, as indicated by the filing type and the checkmark next to 'Definitive Proxy Statement'.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding BIODESIX INC (BDSX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.